Refined By:
Type:  Other
Date Issued:  [2010 TO 2019]

Results 1-15 of 15 (Search time: 0.003 seconds).

Issue DateTitleAuthor(s)
11-Feb-2015Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
225-Sep-2018Bile acid synthesis: From nature to the chemical modification and synthesis and their applications as drugs and nutrientsŠarenac, Dejan ; Mikov, Momir 
31-Jan-2017Bile acids as novel pharmacological agents: The interplay between gene polymorphisms, epigenetic factors and drug responseNebojša Pavlović ; Bojan Stanimirov ; Momir Mikov 
41-Jan-2014C-KIT signaling in cancer treatmentStankov, Karmen ; Popović, Živko; Mikov, Momir 
51-Jan-2019Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this diseaseTanja Šarenac; Momir Mikov 
61-Jan-2019DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal ImpairmentMikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H.
71-Jul-2018An equation for tacrolimus daily dose calculation in renal transplant patients – Simple and cost saving?Rančić N.; Lozanov-Crvenković, Zagorka ; Mikov, Momir ; Vavić N.; Dragojević Simić V.
81-Apr-2012Ethical and legal aspects of oncogenomicsStankov, Karmen ; Drašković, Dragan ; Mikov, Momir 
91-Jan-2012The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseStojancevic M.; Stankov, Karmen ; Mikov, Momir 
101-Jan-2014The influence of intestinal tract and probiotics on the fate of orally administered drugsStojančević M.; Bojić G.; Al Salami H.; Mikov, Momir 
111-Oct-2012An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and SwedenPavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir 
121-Feb-2013Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactionsStankov, Karmen ; Sabo, Ana ; Mikov, Momir 
131-Jan-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
141-Dec-2012Pleiotropic functions of bile acids mediated by the farnesoid X receptorStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
151-Jun-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami